Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

New drug approved to treat HIV-1

(HealthDay)—Tivicay (dolutegravir) has been approved by the U.S. Food and Drug Administration to treat infection with HIV-1, a strain of the virus that causes AIDS.

HIV & AIDS

New federal guidelines for managing occupational exposures to HIV

New guidelines from the United States Public Health Service update the recommendations for the management of healthcare personnel (HCP) with occupational exposure to HIV and use of postexposure prophylaxis (PEP). The guidelines, ...

HIV & AIDS

HIV answers raise new ethical questions

The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical ...

HIV & AIDS

Namibia forced to roll back free condom programme

Reduced donor funding has forced the Namibian government to shrink the supply of free condoms, a government report said Tuesday, threatening the country's fight against sexually transmitted diseases.

HIV & AIDS

Plant-based compound may inhibit HIV

A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.

HIV & AIDS

Platelets block HIV

Scientists of the DPZ have shown that platelet activation inhibits the host cell entry of HIV

HIV & AIDS

Is a common food fungus worsening the AIDS epidemic?

A type of fungus coating much of the stored corn, wheat, rice and nuts in developing countries may be quietly worsening the AIDS epidemic, according to a paper published in the World Mycotoxin Journal.

HIV & AIDS

HIV/AIDS vaccines: Defining what works

Designing an effective HIV/AIDS vaccine is something of a paradox: a good vaccine would be safe and look enough like HIV to kick-start the immune system into neutralizing the virus – but the problem is that this is exactly ...

HIV & AIDS

Marital status reduces risk of death from HIV/AIDS for men

(Medical Xpress)—At the height of the AIDS epidemic in the 1980s men who were married were significantly less likely to die of HIV/AIDS than their divorced or otherwise single counterparts, according to a University of ...

HIV & AIDS

2 stem cell patients stop HIV drugs, no virus seen (Update)

Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.

HIV & AIDS

Hot flashes take heavier toll on women with HIV

Women with HIV are living longer, so more are entering menopause. As they do, they suffer more severe hot flashes than women without HIV, and their hot flashes take a heavier toll on their quality of life and daily functioning, ...

HIV & AIDS

Patents making new AIDS drugs expensive, MSF says

New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.